ReviewCurrent atherosclerosis reports2018
Gender Disparities in CAD: Women and Ischemic Heart Disease.
Review in Current atherosclerosis reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Lacylation of Stearoyl-CoA Desaturase-1 Contributes to the Myocardial Ischemia-Reperfusion Injury Through Regulating Wnt/β-Catenin Signaling.Journal of cardiovascular translational research · 2026Article
- The role of disease history score in the association between depression history and current ME/CFS among US adults.Frontiers in public health · 2026Article
- Global trends and inequalities in hypertensive and ischemic heart disease attributable to high body mass index: A systematic analysis from 1990 to 2021 with projections to 2035.American heart journal plus : cardiology research and practice · 2025Article
- The burden of ischemic heart disease among women of childbearing age in China from 1990 to 2021, and projections for the next 15 years.BMC women's health · 2025Article
- Impact of health awareness on myocardial infarction.The Journal of the Egyptian Public Health Association · 2025Article
- Changing patterns of cardiovascular diseases and subtypes induced by kidney dysfunction among 25-64 years in China from 1992 to 2021.BMC public health · 2025Article
- Article
- Decreased circulating CTRP3 levels in acute and chronic cardiovascular patients.Journal of molecular medicine (Berlin, Germany) · 2024Article
- Article
- Mortality trend analysis of ischemic heart disease in China between 2010 and 2019: a joinpoint analysis.BMC public health · 2023Article
- Role of the renin-angiotensin system in the pathophysiology of coronary heart disease and heart failure: Diagnostic biomarkers and therapy with drugs and natural products.Frontiers in physiology · 2023Review
- Risk of Ischemic Heart Disease Associated with Primary Dysmenorrhea: A Population-Based Retrospective Cohort Study.Journal of personalized medicine · 2022Article
- Your neighborhood matters: A machine-learning approach to the geospatial and social determinants of health in 9-1-1 activated chest pain.Research in nursing & health · 2022Article
- Age at menarche and ischemic heart disease: An update mendelian randomization study.Frontiers in genetics · 2022Article
- Hypertension in Women: A South-Asian Perspective.Frontiers in cardiovascular medicine · 2022Review
- Interaction Between Treatment and Age or Sex in Non-ST-Segment Elevation Acute Coronary Disease and Three-Vessel Disease.Frontiers in cardiovascular medicine · 2022Article
- Vitamin D Deficiency as a Risk Factor for Myocardial Ischemia.Medicina (Kaunas, Lithuania) · 2021Article
- Bioinformatics analysis identifies potential diagnostic signatures for coronary artery disease.The Journal of international medical research · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewThe goal of this article is to review the disparities that exist for women who present for treatment of ischemic heart disease. RECENT
findingsIt is well known that women are more likely to present with ischemic heart disease at an advanced age with more comorbidities when compared to male counterparts. Despite correction of risk factors, women experience worse outcomes, even in the absence of obstructive coronary artery disease. A review of the literature highlights the importance of a thoughtful approach to medical therapy and revascularization. While most recommendations applied to women are derived mostly from male data, further study of sex-specific differences may lead to approaches which can ultimately reduce disparities for the treatment of ischemic heart disease in women.
Indexed as
Identifiers
30178384What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.